Claudio Cabello-Verrugio
Citata da
Citata da
Extracellular proteoglycans modify TGF-β bio-availability attenuating its signaling during skeletal muscle differentiation
R Droguett, C Cabello-Verrugio, C Riquelme, E Brandan
Matrix Biology 25 (6), 332-341, 2006
Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: requirement of syndecan-3 for successful fiber formation
JC Casar, C Cabello-Verrugio, H Olguin, R Aldunate, NC Inestrosa, ...
Journal of cell science 117 (1), 73-84, 2004
A novel modulatory mechanism of transforming growth factor-β signaling through decorin and LRP-1
C Cabello-Verrugio, E Brandan
Journal of Biological Chemistry 282 (26), 18842-18850, 2007
Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-β signalling
MJ Acuña, P Pessina, H Olguin, D Cabrera, CP Vio, M Bader, ...
Human molecular genetics 23 (5), 1237-1249, 2014
Skeletal muscle cells express the profibrotic cytokine connective tissue growth factor (CTGF/CCN2), which induces their dedifferentiation
C Vial, LM Zúñiga, C Cabello‐Verrugio, P Cañón, R Fadic, E Brandan
Journal of cellular physiology 215 (2), 410-421, 2008
Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy
MG Morales, J Gutierrez, C Cabello-Verrugio, D Cabrera, KE Lipson, ...
Human molecular genetics 22 (24), 4938-4951, 2013
Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy
E Brandan, C Cabello-Verrugio, C Vial
Matrix Biology 27 (8), 700-708, 2008
Oxidative stress mediates the conversion of endothelial cells into myofibroblasts via a TGF-β 1 and TGF-β 2-dependent pathway
I Montorfano, A Becerra, R Cerro, C Echeverría, E Sáez, MG Morales, ...
Laboratory investigation 94 (10), 1068-1082, 2014
CTGF/CCN‐2 over‐expression can directly induce features of skeletal muscle dystrophy
MG Morales, C Cabello‐Verrugio, C Santander, D Cabrera, ...
The Journal of pathology 225 (4), 490-501, 2011
Renin‐angiotensin system: an old player with novel functions in skeletal muscle
C Cabello‐Verrugio, MG Morales, JC Rivera, D Cabrera, F Simon
Medicinal research reviews 35 (3), 437-463, 2015
Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells
MG Morales, Y Vazquez, MJ Acuña, JC Rivera, F Simon, JD Salas, JÁ Ruf, ...
The international journal of biochemistry & cell biology 44 (11), 1993-2002, 2012
Angiotensin II receptor type 1 blockade decreases CTGF/CCN2‐mediated damage and fibrosis in normal and dystrophic skeletal muscles
C Cabello‐Verrugio, MG Morales, D Cabrera, CP Vio, E Brandan
Journal of cellular and molecular medicine 16 (4), 752-764, 2012
Endothelial-to-mesenchymal transition: Cytokine-mediated pathways that determine endothelial fibrosis under inflammatory conditions
L Pérez, N Muñoz-Durango, CA Riedel, C Echeverría, AM Kalergis, ...
Cytokine & growth factor reviews 33, 41-54, 2017
Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth …
MG Morales, D Cabrera, C Céspedes, CP Vio, Y Vazquez, E Brandan, ...
Cell and tissue research 353 (1), 173-187, 2013
The low density lipoprotein receptor-related protein functions as an endocytic receptor for decorin
E Brandan, C Retamal, C Cabello-Verrugio, MP Marzolo
Journal of Biological Chemistry 281 (42), 31562-31571, 2006
The internal region leucine-rich repeat 6 of decorin interacts with low density lipoprotein receptor-related protein-1, modulates transforming growth factor (TGF)-β-dependent …
C Cabello-Verrugio, C Santander, C Cofré, MJ Acuña, F Melo, E Brandan
Journal of Biological Chemistry 287 (9), 6773-6787, 2012
Nrf2 signaling and the slowed aging phenotype: evidence from long-lived models
DR Bruns, JC Drake, LM Biela, FF Peelor, BF Miller, KL Hamilton
Oxidative medicine and cellular longevity 2015, 2015
Fibrotic response induced by angiotensin-II requires NAD (P) H oxidase-induced reactive oxygen species (ROS) in skeletal muscle cells
C Cabello-Verrugio, MJ Acuña, MG Morales, A Becerra, F Simon, ...
Biochemical and biophysical research communications 410 (3), 665-670, 2011
Angiotensin-(1–7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism
F Cisternas, MG Morales, C Meneses, F Simon, E Brandan, J Abrigo, ...
Clinical science 128 (5), 307-319, 2015
Betaglycan Expression Is Transcriptionally Up-regulated during Skeletal Muscle Differentiation CLONING OF MURINE BETAGLYCAN GENE PROMOTER AND ITS MODULATION BY MyoD, RETINOIC …
F López-Casillas, C Riquelme, Y Pérez-Kato, MV Ponce-Castañeda, ...
Journal of Biological Chemistry 278 (1), 382-390, 2003
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20